Treatment With Aspirin After Preeclampsia: TAP Trial

Launched by ALISSE HAUSPURG · Feb 19, 2024

Keywords

ClinConnect Summary

The TAP Trial is studying whether low-dose aspirin can help women recover better after experiencing preeclampsia, a serious pregnancy condition that can lead to high blood pressure and other complications. Researchers want to see if taking aspirin in the weeks after giving birth can improve blood vessel function and lower blood pressure for up to six months. The trial is currently looking to enroll up to 60 women who are at least 18 years old and have been diagnosed with preeclampsia.

If you join the study, you will have three visits where your blood pressure will be measured, and some blood tests will be done. You will also answer some questions about your health. The study will compare the effects of low-dose aspirin with a placebo (a sugar pill that has no effect) to see if the aspirin makes a difference. It’s important to note that women with certain conditions, like multiple pregnancies or allergies to aspirin, cannot participate. This trial aims to gather valuable information that could help improve care for women after preeclampsia.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Postpartum individuals ≥18 years old
• • Preeclampsia diagnosis
• Exclusion Criteria:
• • Fetal anomaly
• • Multiple gestation
• • Pre-pregnancy hypertension
• • Allergy or contraindication to low-dose aspirin
• • Pre-pregnancy diabetes